Selected research
Industry Research
Eye Drops and Lubricants Drugs Industry Research Report 2026
Market perspective
The global Eye Drops and Lubricants Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Eye Drops and Lubricants Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Eye Drops and Lubricants Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Eye Drops and Lubricants Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Eye Drops and Lubricants Drugs include ALCON, Johnson & Johnson, URSAPHARM, Thea pharmaceuticals, SIMILASAN, Rohto, Prestige Consumer Healthcare, OmniVision Pharma and Bausch Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Eye Drops and Lubricants Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Eye Drops and Lubricants Drugs Market by Company
ALCON
Johnson & Johnson
URSAPHARM
Thea pharmaceuticals
SIMILASAN
Rohto
Prestige Consumer Healthcare
OmniVision Pharma
Bausch Health
Allergan
Akorn
Eye Drops and Lubricants Drugs Segment by Type
Allergy Eye Care
Standard Eye Care
Eye Drops and Lubricants Drugs Segment by Application
Internet
Optical Chains
Pharmacy
Grocery
Eye Drops and Lubricants Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eye Drops and Lubricants Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eye Drops and Lubricants Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eye Drops and Lubricants Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Eye Drops and Lubricants Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Eye Drops and Lubricants Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Eye Drops and Lubricants Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Allergy Eye Care
- Standard Eye Care
Applications
- Internet
- Optical Chains
- Pharmacy
- Grocery
Companies covered
- ALCON
- Johnson & Johnson
- URSAPHARM
- Thea pharmaceuticals
- SIMILASAN
- Rohto
- Prestige Consumer Healthcare
- OmniVision Pharma
- Bausch Health
- Allergan
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Eye Drops and Lubricants Drugs Market Size (2021-2032)
- 2.2.2 Global Eye Drops and Lubricants Drugs Sales (2021-2032)
- 2.2.3 Global Eye Drops and Lubricants Drugs Market Average Price (2021-2032)
- 2.3 Eye Drops and Lubricants Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Allergy Eye Care
- 2.3.3 Standard Eye Care
- 2.4 Eye Drops and Lubricants Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Internet
- 2.4.3 Optical Chains
- 2.4.4 Pharmacy
- 2.4.5 Grocery
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Eye Drops and Lubricants Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Eye Drops and Lubricants Drugs Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Eye Drops and Lubricants Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Eye Drops and Lubricants Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Eye Drops and Lubricants Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Eye Drops and Lubricants Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Eye Drops and Lubricants Drugs, Product Type & Application
- 3.8 Global Manufacturers of Eye Drops and Lubricants Drugs, Established Date
- 3.9 Global Eye Drops and Lubricants Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ALCON
- 4.1.1 ALCON Company Information
- 4.1.2 ALCON Business Overview
- 4.1.3 ALCON Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ALCON Eye Drops and Lubricants Drugs Product Portfolio
- 4.1.5 ALCON Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Eye Drops and Lubricants Drugs Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 URSAPHARM
- 4.3.1 URSAPHARM Company Information
- 4.3.2 URSAPHARM Business Overview
- 4.3.3 URSAPHARM Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 URSAPHARM Eye Drops and Lubricants Drugs Product Portfolio
- 4.3.5 URSAPHARM Recent Developments
- 4.4 Thea pharmaceuticals
- 4.4.1 Thea pharmaceuticals Company Information
- 4.4.2 Thea pharmaceuticals Business Overview
- 4.4.3 Thea pharmaceuticals Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Thea pharmaceuticals Eye Drops and Lubricants Drugs Product Portfolio
- 4.4.5 Thea pharmaceuticals Recent Developments
- 4.5 SIMILASAN
- 4.5.1 SIMILASAN Company Information
- 4.5.2 SIMILASAN Business Overview
- 4.5.3 SIMILASAN Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SIMILASAN Eye Drops and Lubricants Drugs Product Portfolio
- 4.5.5 SIMILASAN Recent Developments
- 4.6 Rohto
- 4.6.1 Rohto Company Information
- 4.6.2 Rohto Business Overview
- 4.6.3 Rohto Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Rohto Eye Drops and Lubricants Drugs Product Portfolio
- 4.6.5 Rohto Recent Developments
- 4.7 Prestige Consumer Healthcare
- 4.7.1 Prestige Consumer Healthcare Company Information
- 4.7.2 Prestige Consumer Healthcare Business Overview
- 4.7.3 Prestige Consumer Healthcare Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prestige Consumer Healthcare Eye Drops and Lubricants Drugs Product Portfolio
- 4.7.5 Prestige Consumer Healthcare Recent Developments
- 4.8 OmniVision Pharma
- 4.8.1 OmniVision Pharma Company Information
- 4.8.2 OmniVision Pharma Business Overview
- 4.8.3 OmniVision Pharma Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 OmniVision Pharma Eye Drops and Lubricants Drugs Product Portfolio
- 4.8.5 OmniVision Pharma Recent Developments
- 4.9 Bausch Health
- 4.9.1 Bausch Health Company Information
- 4.9.2 Bausch Health Business Overview
- 4.9.3 Bausch Health Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bausch Health Eye Drops and Lubricants Drugs Product Portfolio
- 4.9.5 Bausch Health Recent Developments
- 4.10 Allergan
- 4.10.1 Allergan Company Information
- 4.10.2 Allergan Business Overview
- 4.10.3 Allergan Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Allergan Eye Drops and Lubricants Drugs Product Portfolio
- 4.10.5 Allergan Recent Developments
- 4.11 Akorn
- 4.11.1 Akorn Company Information
- 4.11.2 Akorn Business Overview
- 4.11.3 Akorn Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Akorn Eye Drops and Lubricants Drugs Product Portfolio
- 4.11.5 Akorn Recent Developments
5 Global Eye Drops and Lubricants Drugs Market Scenario by Region
- 5.1 Global Eye Drops and Lubricants Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Eye Drops and Lubricants Drugs Sales by Region: 2021-2032
- 5.2.1 Global Eye Drops and Lubricants Drugs Sales by Region: 2021-2026
- 5.2.2 Global Eye Drops and Lubricants Drugs Sales by Region: 2027-2032
- 5.3 Global Eye Drops and Lubricants Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Eye Drops and Lubricants Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Eye Drops and Lubricants Drugs Revenue by Region: 2027-2032
- 5.4 North America Eye Drops and Lubricants Drugs Market Facts & Figures by Country
- 5.4.1 North America Eye Drops and Lubricants Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Eye Drops and Lubricants Drugs Sales by Country (2021-2032)
- 5.4.3 North America Eye Drops and Lubricants Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Eye Drops and Lubricants Drugs Market Facts & Figures by Country
- 5.5.1 Europe Eye Drops and Lubricants Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Eye Drops and Lubricants Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Eye Drops and Lubricants Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Eye Drops and Lubricants Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Eye Drops and Lubricants Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Eye Drops and Lubricants Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Eye Drops and Lubricants Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Eye Drops and Lubricants Drugs Market Facts & Figures by Country
- 5.7.1 South America Eye Drops and Lubricants Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Eye Drops and Lubricants Drugs Sales by Country (2021-2032)
- 5.7.3 South America Eye Drops and Lubricants Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Eye Drops and Lubricants Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Eye Drops and Lubricants Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Eye Drops and Lubricants Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Eye Drops and Lubricants Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Eye Drops and Lubricants Drugs Sales by Type (2021-2032)
- 6.1.1 Global Eye Drops and Lubricants Drugs Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Eye Drops and Lubricants Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Eye Drops and Lubricants Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Eye Drops and Lubricants Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Eye Drops and Lubricants Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Eye Drops and Lubricants Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Eye Drops and Lubricants Drugs Sales by Application (2021-2032)
- 7.1.1 Global Eye Drops and Lubricants Drugs Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Eye Drops and Lubricants Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Eye Drops and Lubricants Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Eye Drops and Lubricants Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Eye Drops and Lubricants Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Eye Drops and Lubricants Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Eye Drops and Lubricants Drugs Value Chain Analysis
- 8.1.1 Eye Drops and Lubricants Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Eye Drops and Lubricants Drugs Production Mode & Process
- 8.2 Eye Drops and Lubricants Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Eye Drops and Lubricants Drugs Distributors
- 8.2.3 Eye Drops and Lubricants Drugs Customers
9 Global Eye Drops and Lubricants Drugs Analyzing Market Dynamics
- 9.1 Eye Drops and Lubricants Drugs Industry Trends
- 9.2 Eye Drops and Lubricants Drugs Industry Drivers
- 9.3 Eye Drops and Lubricants Drugs Industry Opportunities and Challenges
- 9.4 Eye Drops and Lubricants Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst